EFTR

eFFECTOR Therapeutics, Inc. Common Stock
EFTR

Overview Fund Activity
Delisted

EFTR was delisted on the 2nd of July, 2024.

Back to rankings

30 hedge funds and large institutions have $10.4M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.48%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
4
Increased
6
Reduced
2
Closed
1
Calls
$43K
Puts
–
Net Calls
+$43K
Net Calls Change
-$14K

Top Buyers

1
IDA
1
Intelligence Driven Advisers
California
$24.4K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$14.4K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$94K
4
UBS Group
4
UBS Group
Switzerland
$11.3K
5
TRCT
5
Tower Research Capital (TRC)
New York
$10K

Top Sellers

1
TSS
1
Two Sigma Securities
New York
$0
2
WFAG
2
Wescott Financial Advisory Group
Pennsylvania
$17.3K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$16.5K
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
26
Simplex Trading
Illinois
$3K +$1.02K +117 +52%
Morgan Stanley
27
Morgan Stanley
New York
$2.57K – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$1K – – –
Wells Fargo
29
Wells Fargo
California
$32 – – –
Bank of America
30
Bank of America
North Carolina
$20 +$20 +2 New
TSS
31
Two Sigma Securities
New York
– -$9K -648 Closed
1
2